{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:50:59Z","timestamp":1791517859529,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1245\/s10434-021-10848-8","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T03:00:13Z","timestamp":1634612413000},"page":"1437-1448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1245","volume":"29","author":[{"given":"Koji","family":"Kubota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5015-1697","authenticated-orcid":false,"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Notake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Masuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koya","family":"Yasukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kamachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamune","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"10848_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/bjs.8763","volume":"99","author":"P Sanjay","year":"2012","unstructured":"Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA. \u201cArtery-first\u201d approaches to pancreatoduodenectomy. Br J Surg. 2012;99:1027\u201335.","journal-title":"Br J Surg."},{"key":"10848_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1499-3872(16)60134-0","volume":"16","author":"I Negoi","year":"2017","unstructured":"Negoi I, Hostiuc S, Runcanu A, Negoi RI, Beuran M. Superior mesenteric artery first approach versus standard pancreaticoduodenectomy: a systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int. 2017;16:127\u201338.","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"10848_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2020.3537","volume":"6","author":"S van Roessel","year":"2020","unstructured":"van Roessel S, van Veldhuisen E, Klompmaker S, et al. Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant folfirinox treatment. JAMA Oncol. 2020;6:1\u20138.","journal-title":"JAMA Oncol."},{"key":"10848_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/jjco\/hyy190","volume":"49","author":"F Motoi","year":"2019","unstructured":"Motoi F, Kosuge T, Ueno H, et al. Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05). Jpn J Clin Oncol. 2019;49:190\u20134.","journal-title":"Jpn J Clin Oncol."},{"key":"10848_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"10848_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"10848_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539\u201345.","journal-title":"Lancet"},{"key":"10848_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073\u201381.","journal-title":"Carcinogenesis"},{"key":"10848_CR9","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-503.","journal-title":"Lancet Oncol"},{"key":"10848_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/983698","volume":"2015","author":"E Uribe-Querol","year":"2015","unstructured":"Uribe-Querol E, Rosales C. Neutrophils in cancer: two sides of the same coin. J Immunol Res. 2015;2015:983698.","journal-title":"J Immunol Res."},{"key":"10848_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1748-717X-5-47","volume":"5","author":"J Kitayama","year":"2010","unstructured":"Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol. 2010;5:47.","journal-title":"Radiat Oncol."},{"key":"10848_CR12","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.1007\/s13277-015-3560-6","volume":"36","author":"LN Zhang","year":"2015","unstructured":"Zhang LN, Xiao W, Yang PY, et al. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy. Tumour Biol. 2015;36:8213\u20139.","journal-title":"Tumour Biol."},{"key":"10848_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","volume":"33","author":"DG Menter","year":"2014","unstructured":"Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 2014;33:231\u201369.","journal-title":"Cancer Metastasis Rev."},{"key":"10848_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.","journal-title":"Nutr J."},{"key":"10848_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/10408363.2011.599831","volume":"48","author":"KH Allin","year":"2011","unstructured":"Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48:155\u201370.","journal-title":"Crit Rev Clin Lab Sci."},{"key":"10848_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2007-994914","volume":"25","author":"M Monreal","year":"1999","unstructured":"Monreal M, Prandoni P. Venous thromboembolism as first manifestation of cancer. Semin Thromb Hemost. 1999;25:131\u20136.","journal-title":"Semin Thromb Hemost."},{"key":"10848_CR17","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/bjs.1800801116","volume":"80","author":"CM Edwards","year":"1993","unstructured":"Edwards CM, Warren J, Armstrong L, Donnelly PK. D-dimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg. 1993;80:1404\u20135.","journal-title":"Br J Surg."},{"key":"10848_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/CBM-160510","volume":"19","author":"T Hong","year":"2017","unstructured":"Hong T, Shen D, Chen X, Wu X, Hua D. Preoperative plasma fibrinogen, but not D-dimer might represent a prognostic factor in non-metastatic colorectal cancer: a prospective cohort study. Cancer Biomark. 2017;19:103\u201311.","journal-title":"Cancer Biomark."},{"key":"10848_CR19","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ejso.2018.07.052","volume":"44","author":"Y Lin","year":"2018","unstructured":"Lin Y, Liu Z, Qiu Y, et al. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2018;44:1494\u2013503.","journal-title":"Eur J Surg Oncol."},{"key":"10848_CR20","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00595-016-1308-6","volume":"46","author":"J Watanabe","year":"2016","unstructured":"Watanabe J, Otani S, Sakamoto T, et al. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today. 2016;46:1258\u201367.","journal-title":"Surg Today"},{"key":"10848_CR21","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1245\/s10434-016-5634-0","volume":"24","author":"M Sierzega","year":"2017","unstructured":"Sierzega M, Lenart M, Rutkowska M, et al. Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer. Ann Surg Oncol. 2017;24:808\u201315.","journal-title":"Ann Surg Oncol."},{"key":"10848_CR22","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","volume":"21","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG. Prognostic significance of neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21:2807\u201315.","journal-title":"World J Gastroenterol."},{"key":"10848_CR23","first-page":"1085","volume":"9","author":"GJ Li","year":"2016","unstructured":"Li GJ, Xu HW, Ji JJ, Yang F, Gao BQ. Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma. Onco Targets Ther. 2016;9:1085\u201392.","journal-title":"Onco Targets Ther."},{"key":"10848_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011002","volume":"97","author":"J Yu","year":"2018","unstructured":"Yu J, Ding Z, Yang Y, Liu S. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery. Med Baltimore. 2018;97:e11002.","journal-title":"Med Baltimore"},{"key":"10848_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4143\/crt.2020.330","volume":"53","author":"L Fang","year":"2021","unstructured":"Fang L, Yan FH, Liu C, et al. Systemic inflammatory biomarkers, especially fibrinogen-to-albumin ratio, predict prognosis in patients with pancreatic cancer. Cancer Res Treat. 2021;53:131\u20139.","journal-title":"Cancer Res Treat."},{"key":"10848_CR26","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.2147\/CMAR.S204938","volume":"11","author":"N Fan","year":"2019","unstructured":"Fan N, Chen D, Zheng J, Wen Z, Lin P. A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio. Cancer Manag Res. 2019;11:4719\u201328.","journal-title":"Cancer Manag Res."},{"key":"10848_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00595-018-1734-8","volume":"49","author":"K Wakatsuki","year":"2019","unstructured":"Wakatsuki K, Matsumoto S, Migita K, et al. Prognostic value of the fibrinogen-to-platelet ratio as an inflammatory and coagulative index in patients with gastric cancer. Surg Today. 2019;49:334\u201342.","journal-title":"Surg Today"},{"key":"10848_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020595","volume":"99","author":"Y Zang","year":"2020","unstructured":"Zang Y, Fan Y, Gao Z. Pretreatment C-reactive protein\/albumin ratio for predicting overall survival in pancreatic cancer: a meta-analysis. Med Baltimore. 2020;99:e20595.","journal-title":"Med Baltimore"},{"key":"10848_CR29","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/jso.26109","volume":"122","author":"K Yasukawa","year":"2020","unstructured":"Yasukawa K, Shimizu A, Motoyama H, et al. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients. J Surg Oncol. 2020;122:1094\u2013105.","journal-title":"J Surg Oncol."},{"key":"10848_CR30","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.","journal-title":"J Natl Cancer Inst."},{"key":"10848_CR31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/jso.24523","volume":"115","author":"A Haram","year":"2017","unstructured":"Haram A, Boland MR, Kelly ME, Bolger JC, Waldron RM, Kerin MJ. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review. J Surg Oncol. 2017;115:470\u20139.","journal-title":"J Surg Oncol."},{"key":"10848_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12957-020-01962-0","volume":"18","author":"S Lin","year":"2020","unstructured":"Lin S, Fang Y, Mo Z, Lin Y, Ji C, Jian Z. Prognostic value of lymphocyte-to-monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients. World J Surg Oncol. 2020;18:186.","journal-title":"World J Surg Oncol."},{"key":"10848_CR33","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.21873\/anticanres.13331","volume":"39","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, Taniguchi K, Asakuma M, et al. Lymphocyte-to-monocyte ratio and prognostic nutritional index predict poor prognosis in patients on chemotherapy for unresectable pancreatic cancer. Anticancer Res. 2019;39:2169\u201376.","journal-title":"Anticancer Res."},{"key":"10848_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.7150\/jca.16491","volume":"8","author":"Z Tan","year":"2017","unstructured":"Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the fibrinogen\/albumin ratio. J Cancer. 2017;8:1025\u20139.","journal-title":"J Cancer."},{"key":"10848_CR35","volume-title":"AJCC Cancer Staging Manual","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AI, editors. AJCC Cancer Staging Manual. 7th edn. New York: Springer; 2010.","edition":"7"},{"key":"10848_CR36","first-page":"2553","volume":"8","author":"TK Hoffmann","year":"2002","unstructured":"Hoffmann TK, Dworacki G, Tsukihiro T, et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 2002;8:2553\u201362.","journal-title":"Clin Cancer Res."},{"key":"10848_CR37","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.21873\/anticanres.14264","volume":"40","author":"R Tanaka","year":"2020","unstructured":"Tanaka R, Kimura K, Eguchi S, et al. Preoperative neutrophil-to-lymphocyte ratio predicts tumor-infiltrating CD8(+) T cells in biliary tract cancer. Anticancer Res. 2020;40:2881\u20137.","journal-title":"Anticancer Res."},{"key":"10848_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1479-5876-10-33","volume":"10","author":"K Milne","year":"2012","unstructured":"Milne K, Alexander C, Webb JR, et al. Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J Transl Med. 2012;10:33.","journal-title":"J Transl Med."},{"key":"10848_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26:78.","journal-title":"J Biomed Sci."},{"key":"10848_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13402-019-00453-z","volume":"42","author":"A Salmaninejad","year":"2019","unstructured":"Salmaninejad A, Valilou SF, Soltani A, et al. Tumor-associated macrophages: role in cancer development and therapeutic implications. Cell Oncol Dordr. 2019;42:591\u2013608.","journal-title":"Cell Oncol Dordr."},{"key":"10848_CR41","doi-asserted-by":"publisher","first-page":"E4236","DOI":"10.1073\/pnas.1722020115","volume":"115","author":"L Suarez-Lopez","year":"2018","unstructured":"Suarez-Lopez L, Sriram G, Kong YW, et al. MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis. Proc Natl Acad Sci U S A. 2018;115:E4236\u201344.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10848_CR42","first-page":"9345","volume":"20","author":"BR Boulay","year":"2014","unstructured":"Boulay BR, Parepally M. Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy. World J Gastroenterol. 2014;20:9345\u201353.","journal-title":"World J Gastroenterol."},{"key":"10848_CR43","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00432-019-02982-4","volume":"145","author":"M Li","year":"2019","unstructured":"Li M, Spakowicz D, Burkart J, et al. Change in neutrophil-to-lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers. J Cancer Res Clin Oncol. 2019;145:2541\u20136.","journal-title":"J Cancer Res Clin Oncol."},{"key":"10848_CR44","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.2147\/OTT.S117290","volume":"9","author":"F Jin","year":"2016","unstructured":"Jin F, Han A, Shi F, Kong L, Yu J. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer. Onco Targets Ther. 2016;9:6529\u201337.","journal-title":"Onco Targets Ther."},{"key":"10848_CR45","doi-asserted-by":"publisher","first-page":"1451864","DOI":"10.1155\/2020\/1451864","volume":"2020","author":"Q Song","year":"2020","unstructured":"Song Q, Wu JZ, Jiang HF, Wang S, Cai SN. The postoperative lymphocyte-to-monocyte ratio change predicts poor clinical outcome in patients with esophageal squamous cell carcinoma undergoing curative resection. Dis Markers. 2020;2020:1451864.","journal-title":"Dis Markers."},{"key":"10848_CR46","first-page":"533","volume":"49","author":"JO Winters","year":"1983","unstructured":"Winters JO, Leider ZL. The value of instant nutritional assessment in predicting postoperative complications and death in gastrointestinal surgical patients. Am Surg. 1983;49:533\u20135.","journal-title":"Am Surg."},{"key":"10848_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/bjs.1800730121","volume":"73","author":"RA Pettigrew","year":"1986","unstructured":"Pettigrew RA, Hill GL. Indicators of surgical risk and clinical judgement. Br J Surg. 1986;73:47\u201351.","journal-title":"Br J Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10848-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10848-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10848-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T19:18:45Z","timestamp":1675797525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10848-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10848"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10848-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"19 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}